Mechanistically, 4-HPA activates JAK2/STAT3 signaling in CRC cells to induce CXCL3 expression, thereby recruiting PMN-MDSCs via CXCR2 and impairing CD8+ T cell effector function, ultimately promoting ICI resistance. Here, CD8A is linked to colorectal carcinoma.